Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Chemomab Therapeutics Announced Publication Of Proteomic Analyses That Further Demonstrate The Unique Role Of The Soluble Protein CCL24 In Driving Pathologies Associated With The Rare Fibrotic Liver Disease Primary Sclerosing Cholangitis

Author: Benzinga Newsdesk | January 30, 2024 08:05am

Posted In: CMMB